Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HAROLD J MILSTEIN

Allopathic & Osteopathic Physicians Dermatology

NPI
1083684344
CMS profile
94589
Location
PHILADELPHIA, PA

General Payments · PY2018–2024

$184,932.02

  • Reported across 1,175 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,195.71

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $3,300.00 1
Food and Beverage $895.71 34

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $69,126.28 228
PY2019 $52,467.49 224
PY2020 $10,366.05 111
PY2021 $17,759.79 211
PY2022 $28,389.58 283
PY2023 $2,627.12 83
PY2024 $4,195.71 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $26.03 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105041313 CMS
ABBVIE INC. $25.06 06/06/2024 Food and Beverage Undisputed 01/23/2026 1105041315 CMS
ABBVIE INC. $14.02 09/12/2024 Food and Beverage Undisputed 01/23/2026 1105041317 CMS
ABBVIE INC. $15.54 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105041319 CMS
ABBVIE INC. $13.73 12/19/2024 Food and Beverage Undisputed 01/23/2026 1105041321 CMS
Galderma Laboratories, L.P. $28.92 02/13/2024 Food and Beverage Undisputed 01/23/2026 1145316479 CMS
Galderma Laboratories, L.P. $9.13 09/04/2024 Food and Beverage Undisputed 01/23/2026 1145316481 CMS
Galderma Laboratories, L.P. $14.14 09/11/2024 Food and Beverage Undisputed 01/23/2026 1145316483 CMS
Galderma Laboratories, L.P. $19.95 10/25/2024 Food and Beverage Undisputed 01/23/2026 1145316485 CMS
Galderma Laboratories, L.P. $83.03 10/26/2024 Food and Beverage Undisputed 01/23/2026 1145316487 CMS
Galderma Laboratories, L.P. $8.97 12/05/2024 Food and Beverage Undisputed 01/23/2026 1145316489 CMS
Janssen Biotech, Inc. $24.49 01/11/2024 Food and Beverage Undisputed 01/23/2026 1078589256 CMS
Janssen Biotech, Inc. $36.02 10/15/2024 Food and Beverage Undisputed 01/23/2026 1078588940 CMS
Lilly USA, LLC $15.83 07/24/2024 Food and Beverage Undisputed 01/23/2026 1134997716 CMS
Novartis Pharmaceuticals Corporation $18.05 02/06/2024 Food and Beverage Undisputed 01/23/2026 1087148842 CMS
Novartis Pharmaceuticals Corporation $17.91 02/08/2024 Food and Beverage Undisputed 01/23/2026 1087148846 CMS
Novartis Pharmaceuticals Corporation $2.91 02/08/2024 Food and Beverage Undisputed 01/23/2026 1087148848 CMS
Novartis Pharmaceuticals Corporation $20.06 02/16/2024 Food and Beverage Undisputed 01/23/2026 1087148854 CMS
Novartis Pharmaceuticals Corporation $16.84 04/11/2024 Food and Beverage Undisputed 01/23/2026 1087148852 CMS
Novartis Pharmaceuticals Corporation $7.82 05/09/2024 Food and Beverage Undisputed 01/23/2026 1087148856 CMS
Novartis Pharmaceuticals Corporation $9.53 06/06/2024 Food and Beverage Undisputed 01/23/2026 1087148858 CMS
Novartis Pharmaceuticals Corporation $16.43 07/11/2024 Food and Beverage Undisputed 01/23/2026 1087148862 CMS
Novartis Pharmaceuticals Corporation $14.29 08/15/2024 Food and Beverage Undisputed 01/23/2026 1087148872 CMS
Novartis Pharmaceuticals Corporation $8.80 09/12/2024 Food and Beverage Undisputed 01/23/2026 1087148870 CMS
Novartis Pharmaceuticals Corporation $24.22 10/18/2024 Food and Beverage Undisputed 01/23/2026 1087148882 CMS
Novartis Pharmaceuticals Corporation $39.73 10/24/2024 Food and Beverage Undisputed 01/23/2026 1087148886 CMS
Novartis Pharmaceuticals Corporation $171.68 10/24/2024 Food and Beverage Undisputed 01/23/2026 1087148890 CMS
Novartis Pharmaceuticals Corporation $3,300.00 10/24/2024 Consulting Fee Undisputed 01/23/2026 1087148892 CMS
Novartis Pharmaceuticals Corporation $14.23 11/14/2024 Food and Beverage Undisputed 01/23/2026 1087148880 CMS
Novartis Pharmaceuticals Corporation $7.83 11/14/2024 Food and Beverage Undisputed 01/23/2026 1087148884 CMS
Novartis Pharmaceuticals Corporation $8.72 12/12/2024 Food and Beverage Undisputed 01/23/2026 1087148888 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $13.22 09/11/2024 Food and Beverage Undisputed 01/23/2026 1153809621 CMS
Paratek Pharmaceuticals, Inc. $15.37 08/13/2024 Food and Beverage Undisputed 01/23/2026 1113910652 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $26.59 05/23/2024 Food and Beverage Undisputed 01/23/2026 1152152679 CMS
Verrica Pharmaceuticals Inc. $106.62 05/07/2024 Food and Beverage Undisputed 01/23/2026 1118384216 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.